Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Some studies suggest it may influence glucose metabolism through activation of AMP-activated protein kinase (AMPK), an enzyme involved in cellular energy regulation
According to NICE guideline NG28, GLP-1 receptor agonists should be considered when: Triple therapy (metformin and two other oral drugs) is not effective, not tolerated, or contraindicated The patient has a BMI 35 kg/m (or lower in people of Black, Asian and other minority ethnic groups) and specific obesity-related comorbidities The patient has a BMI 40% reduction in non-HDL cholesterol GLP-1 receptor agonist for glycaemic control and weight management (with secondary lipid benefits) Ezetimibe if non-HDL cholesterol reduction is insufficient Lifestyle interventions addressing diet, exercise, and weight Monitoring and follow-up are essential components of cholesterol management
People with a family history of medullary thyroid carcinoma (a type of thyroid cancer) or those with Multiple Endocrine Neoplasia syndrome type 2 should also avoid Semaglutide due to the potential risk of thyroid tumors
Your lifestyle habits Your lifestyle habits Semaglutide, when used in combination with a healthy diet, taking good care of your body, exercise, adequate sleep, and less stress, will help you achieve your weight loss goals quickly
US$ 21.61
US$ 20.87
US$ 20.30
US$ 26.66
